Working on Wellness (WOW) Intervention (WOW)
The main aim of this study is to measure the effectiveness of a worksite health promotion programme on improving physical activity behaviour and associated biological risk factors for cardiovascular disease among South African employees at increased risk for cardiovascular diseases. Additionally, the investigators will conduct an economic evaluation to determine the associated cost- effectiveness of these health related interventions offered at South African companies.
The investigators hypothesize that employees who receive the intervention counseling will have increased levels of physical activity and reduced risk for cardiovascular disease compared to those in the control group.
|Study Design:||Intervention Model: Single Group Assignment
Masking: Single Blind (Subject)
Primary Purpose: Prevention
|Official Title:||Working on Wellness (WOW): A Worksite Health Promotion Intervention Programme|
- Effectiveness of a worksite intervention on physical activity behavior [ Time Frame: 12 months ]The Global Physical Activity Questionnaire will be used for self reported levels of physical activity. Weekly time spent in moderate and vigorous activity will be reported.
- Risk for cardiovascular disease [ Time Frame: 12 months ]The risk for cardiovascular disease will be based on blood pressure and cholesterol measurements, Body Mass Index, smoking status and dietary behavior
|Study Start Date:||November 2009|
|Estimated Study Completion Date:||June 2012|
|Primary Completion Date:||May 2011 (Final data collection date for primary outcome measure)|
Experimental: Lifestyle intervention
Participants will receive the intervention (counseling) or usual care (control group)
Behavioral: Wellness counseling
Each participant will receive up to six counseling sessions where the counselor will employ motivational interviewing techniques. The first and last session will be face-to-face with the remaining four sessions being telephonic.
Other Name: Motivational Interviewing counseling
Show Detailed Description
Please refer to this study by its ClinicalTrials.gov identifier: NCT01494207
|University of Cape Town|
|Cape Town, South Africa, 7725|
|Principal Investigator:||Tracy L Kolbe-Alexander, PhD||University of Cape Town|